1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Kidney Disease Global Clinical Trials Review, H2, 2015

Kidney Disease Global Clinical Trials Review, H2, 2015

  • September 2015
  • -
  • Global Data
  • -
  • 152 pages

Kidney Disease Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Kidney Disease Global Clinical Trials Review, H2, 2015" provides an overview of Kidney Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Kidney Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Kidney Disease Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Kidney Disease 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Kidney Disease to Genito Urinary System And Sex Hormones Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Kidney Disease to Genito Urinary System And Sex Hormones Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Kidney Disease 25
Subjects Recruited Over a Period of Time 52
Clinical Trials by Sponsor Type 53
Prominent Sponsors 54
Top Companies Participating in Kidney Disease Therapeutics Clinical Trials 55
Prominent Drugs 56
Clinical Trial Profiles 57
Clinical Trial Overview of Top Companies 57
Novartis AG 57
Clinical Trial Overview of Novartis AG 57
F. Hoffmann-La Roche Ltd. 63
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 63
Amgen Inc. 68
Clinical Trial Overview of Amgen Inc. 68
Sanofi 72
Clinical Trial Overview of Sanofi 72
AbbVie Inc. 77
Clinical Trial Overview of AbbVie Inc. 77
Pfizer Inc. 82
Clinical Trial Overview of Pfizer Inc. 82
Astellas Pharma Inc. 86
Clinical Trial Overview of Astellas Pharma Inc. 86
Merck and Co., Inc. 89
Clinical Trial Overview of Merck and Co., Inc. 89
AstraZeneca Plc 92
Clinical Trial Overview of AstraZeneca Plc 92
Bayer AG 94
Clinical Trial Overview of Bayer AG 94
Clinical Trial Overview of Top Institutes / Government 96
The National Institute of Diabetes and Digestive and Kidney Diseases 96
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 96
Mayo Clinic 99
Clinical Trial Overview of Mayo Clinic 99
Seoul National University Hospital 101
Clinical Trial Overview of Seoul National University Hospital 101
Shiraz University of Medical Sciences 103
Clinical Trial Overview of Shiraz University of Medical Sciences 103
Tehran University of Medical Sciences 104
Clinical Trial Overview of Tehran University of Medical Sciences 104
The National Institute of Allergy and Infectious Diseases 106
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 106
Austin Health 107
Clinical Trial Overview of Austin Health 107
Vanderbilt University 108
Clinical Trial Overview of Vanderbilt University 108
Isfahan University of Medical Sciences 110
Clinical Trial Overview of Isfahan University of Medical Sciences 110
Medical University of Vienna 111
Clinical Trial Overview of Medical University of Vienna 111
Five Key Clinical Profiles 112
Appendix 149
Abbreviations 149
Definitions 149
Research Methodology 150
Secondary Research 150
About GlobalData 151
Contact Us 151
Disclaimer 151
Source 152

List of Tables
Kidney Disease Therapeutics, Global, Clinical Trials by Region, 2015* 7
Kidney Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Kidney Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Kidney Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Kidney Disease Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Kidney Disease Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Kidney Disease Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13
Kidney Disease Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14
Proportion of Kidney Disease to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2015* 15
Kidney Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Kidney Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Kidney Disease to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2015* 18
Kidney Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Kidney Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Kidney Disease Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Kidney Disease Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Kidney Disease Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Kidney Disease Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Kidney Disease Therapeutics, Global, Suspended Clinical Trials, 2015* 25
Kidney Disease Therapeutics, Global, Withdrawn Clinical Trials, 2015* 27
Kidney Disease Therapeutics, Global, Terminated Clinical Trials, 2015* 36
Kidney Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 52
Kidney Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 53
Kidney Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 54
Kidney Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 55
Kidney Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 56
Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 57
Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 63
Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2015* 68
Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2015* 72
Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2015* 77
Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 82
Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2015* 86
Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck and Co., Inc., 2015* 89
Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca Plc, 2015* 92
Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015* 94
Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2015* 96
Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2015* 99
Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2015* 101
Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Shiraz University of Medical Sciences, 2015* 103
Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2015* 104
Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2015* 106
Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Austin Health, 2015* 107
Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2015* 108
Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Isfahan University of Medical Sciences, 2015* 110
Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2015* 111

List of Figures
Kidney Disease Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Kidney Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Kidney Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Kidney Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Kidney Disease Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Kidney Disease Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Kidney Disease Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13
Kidney Disease Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 14
Proportion of Kidney Disease to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2015* 15
Kidney Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Kidney Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Kidney Disease to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2015* 18
Kidney Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Kidney Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Kidney Disease Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Kidney Disease Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Kidney Disease Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Kidney Disease Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Kidney Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 52
Kidney Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 53
Kidney Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 54
Kidney Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 55
Kidney Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 56
GlobalData Methodology 150

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.